Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Update

Oxford Biomedica plc (OTCMKTS:OXBDF) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 134,600 shares, a growth of 71.9% from the February 28th total of 78,300 shares. Based on an average daily volume of 2,000 shares, the days-to-cover ratio is currently 67.3 days. Approximately 0.1% of the company’s shares are short sold.

Oxford Biomedica Stock Performance

Shares of OTCMKTS:OXBDF remained flat at $3.88 during trading on Friday. The company has a current ratio of 2.35, a quick ratio of 2.07 and a debt-to-equity ratio of 1.48. The firm’s 50-day simple moving average is $4.49 and its two-hundred day simple moving average is $4.92. Oxford Biomedica has a 12 month low of $2.44 and a 12 month high of $5.68.

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.